Factoring in acquisition interest for Consumer Healthcare
17/01/22 -"Moreover, with the possible monetisation of Consumer Healthcare, the firm should have sizeable resources at its disposal to expedite mega-transformation initiatives. As a result, we have removed the ..."
Pages
66
Language
English
Published on
17/01/22
You may also be interested by these reports :
27/02/26
The Q4 results were ahead of consensus, but a lack of 2026 sales guidance casts doubt over Grifols’ ability to deliver on its 2029 sales and ...
27/02/26
The Q4 sales exceeded expectations, though ‘adjusted’ EBITDA was somewhat behind the consensus. The Q4 performance was driven by LatAm, Animal ...
26/02/26
Even though the H2 25 results were ahead of consensus, the 2026 outlook was below the street’s expectations. While Branded posted strong H2 growth, ...
26/02/26
Novonesis stumbled at the finish line — Q4 25 revenue and EBITDA missed consensus by 2.3% and 2.9% respectively, dragged down by weakness in the ...